VolitionRX

VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor a range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.

News

Penny Stocks

Small Cap

Pre-Market Outlook

Markets

Movers

Trading Ideas

ACON

ATXG

CLDI

CLEU

CREV

FWBI

GLYC

MDIA

NEXI

PNST

RVSN

SASI

TPHS

VNRX

VRAX

YOSH

ZCAR

Shares of  Trinity Place Holdings Inc. (NYSE: TPHS) rose sharply in pre-market trading.

The company reported in 8K Filing, mortgage lender agreed to extend the mortgage loan forbearance period to Jan. 31, 2024.

Trinity Place shares jumped 80.1% to $0.2056 in pre-market trading.

Why Trinity Place Holdings Shares Are Trading Higher By 80%; Here Are 20 Stocks Moving Premarket

Long Ideas

Insider Trades

IOBT

KORE

The Dow Jones closed higher by over 100 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

IO Biotech And 2 Other Stocks Under $2 Insiders Are Buying

IVFH

ONDS

The Dow Jones closed higher by around 2 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company&#39;s prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Ondas Holdings And 2 Other Stocks Under $1 Insiders Are Buying

VolitionRX Ltd

Press Releases

Study shows Nu.Q® Lung Cancer Test differentiated malignant and benign nodules found by Low Dose CT screening

VolitionRx Appoints LifeSci Advisors as Investor Relations Consultants

Volition Issues Business Review 2024

Large clinical study establishes Nu.Q® NETs H3.1 as an independent predictor of 28-day mortality in sepsis

Volition to Host Virtual Investor Event on Nu.Q® NETs, "Casting a New Light on Sepsis Management", on February 14, 2025

Volition Signs First Commercial Project Utilizing Rapid High-Throughput Model in the Study of NETosis

Volition Showcases Nu.Q® Vet Cancer Test at the 97th WVC Annual Conference

Volition's Nu.Q® Discover Biomarkers to be utilized in Human Clinical Study Sponsored by Leading Pharmaceutical Company for the First Time

Volition Announces First Patient Enrolled in NTU Hospital's Prospective Validation Study of Nu.Q® Lung Cancer Test

Contracts

Volition Signs first ever Nu.Q® Vet Cancer Test Automation Agreement with Fujifilm Vet Systems

Advanced Biomed

Avanos Medical

Bioventus

Cerus

Embecta

OrthoPediatrics

Innovative Eyewear

Meihua International Medical Technologies Co., Ltd. - Ordinary Shares

Meihua Intl Medical Techs

InspireMD

NexGel

OraSure Technologies, Inc. - Common Stock

OraSure Technologies

Rockwell Medical

Retractable Technologies, Inc. Common Stock

Retractable Technologies

Sanara MedTech

Sharps Technology

TELA Bio

Utah Medical Products, Inc. - Common Stock

Utah Medical Products

WORK Medical Technology Group LTD - Class A Ordinary Shares

WORK Medical Tech Gr

Xtant Medical Holdings, Inc. Common Stock

Xtant Medical Hldgs

D. Boral Capital

EF Hutton

Cantor Fitzgerald

Comments

VolitionRX

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga